S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:CYTK

Cytokinetics SEC Filings & 10K Form

$35.50
-2.65 (-6.95%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$35.01
$38.50
50-Day Range
$33.59
$41.73
52-Week Range
$16.05
$42.87
Volume
1.48 million shs
Average Volume
864,698 shs
Market Capitalization
$2.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.21

Cytokinetics (NASDAQ:CYTK) SEC Filings

DateFilerForm TypeView
09/13/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2021
6:17 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:00 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2021
5:59 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2021
4:02 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2021
11:45 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2021
4:14 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2021
8:42 AM
Cytokinetics (Filer)
Form 8-K/A
07/19/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2021
11:07 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G
07/08/2021
4:32 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:32 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:32 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:32 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:31 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:31 PM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:31 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
5:01 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
3:22 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
4:24 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2021
3:28 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
5:28 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
3:45 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2021
3:32 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2021
7:04 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:04 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:03 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:03 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:02 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:02 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:02 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:01 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:01 PM
COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:01 PM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
7:01 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
5:46 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
4:46 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
4:40 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2021
4:32 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
5:55 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2021
4:31 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2021
3:21 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2021
5:13 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4/A
04/08/2021
5:12 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
5:50 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:48 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:48 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:47 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:47 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:47 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:46 PM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
4:46 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
5:55 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
4:37 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2021
5:58 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
3:50 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
3:39 PM
Cytokinetics (Filer)
Form 10-Q/A
03/09/2021
5:56 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
5:56 PM
Cytokinetics (Issuer)
SCHLOSSBERG MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
5:55 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
5:55 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
5:55 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
5:54 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
5:10 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:33 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:32 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:32 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:31 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:00 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
3:59 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
3:59 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
5:25 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
4:17 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
4:02 PM
Cytokinetics (Subject)
Eastern Capital LTD (Filed by)
Form SC 13G/A
02/19/2021
3:19 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
7:28 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
3:26 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/18/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
2:16 PM
Cytokinetics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/12/2021
4:37 PM
Cytokinetics (Issuer)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
4:36 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
9:46 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2021
9:07 AM
Cytokinetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/02/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
3:35 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
3:35 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
01/13/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
5:19 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.